Fundamental Data for YMI

Enter Symbol

Overview

Community Research

Related News

YM BIOSCI(AMEX:YMI)

YM BioSciences Inc. is a cancer drug development company.

# Employees: 37

Address: 5045 Orbitor Drive Suite 400 Building 11,Mississauga,ON,CAN

Phone: 905-629-9761

Fax: 905-629-4959

Website: www.ymbiosciences.com

Email: ir@ymbiosciences.com

Sector: Medical

Industry: MED-BIOMED/GENE

Executive Officers

David G.p. Allan (Chmn.; C.E.O.; Dir.)

Thomas I.a. Allen (Q.C.)

Dir. (Mark Entwistle M.A)

Dir. (Henry Friesen C.C.)

Dir. (Philip Frost M.D,Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/5/2010

Mean EPS (Next Qtr): ($0.06)

Mean EPS (Year): ($0.26)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 2

Shares Performance

Period	YMI	Compare to S&P
YTD	227.20 %	170.80 %
4 Weeks	-4.72 %	-5.75 %
12 Weeks	-35.98 %	-39.64 %

Shares Information

Analyst Coverage: Y

Avg Volume: 379914

Shares Outstanding: 55M

Market Cap: $0.07B

52 Week High: $1.92

52 Week Low: $0.23

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 YMI split by factor of 1.500

Earnings Performance

EPS Growth in Last Quarter: -20.00 %

EPS Growth in Last Year: -20.00 %

Sales Growth in Last Quarter: -2.88 %

Sales Growth in Last Quarter: -55.67 %

Financials

Qtr Book Value: $2.03

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: 16.490